Shandong Intco Medical Products Co Ltd (SHE:300677) — Stock Price
Shandong Intco Medical Products Co Ltd (SHE:300677) is currently trading at CN¥49.60 CNY, down 1.86% today. Over the past 52 weeks, shares have ranged between CN¥34.00 and CN¥65.66. This page tracks Shandong Intco Medical Products Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Shandong Intco Medical Products Co Ltd (300677) market capitalisation.
Shandong Intco Medical Products Co Ltd (300677) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Shandong Intco Medical Products Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Shandong Intco Medical Products Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Shandong Intco Medical Products Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CN¥9.52 Billion | CN¥6.92 Billion | CN¥6.61 Billion | CN¥16.24 Billion | CN¥13.84 Billion |
| Cost of Revenue | CN¥7.35 Billion | CN¥5.98 Billion | CN¥5.78 Billion | CN¥6.27 Billion | CN¥4.29 Billion |
| Gross Profit | CN¥2.18 Billion | CN¥942.35 Million | CN¥837.65 Million | CN¥9.97 Billion | CN¥9.55 Billion |
| Research & Development | CN¥398.34 Million | CN¥283.37 Million | CN¥252.32 Million | CN¥365.22 Million | CN¥293.30 Million |
| SG&A | CN¥518.14 Million | CN¥486.51 Million | CN¥394.56 Million | CN¥538.01 Million | CN¥240.05 Million |
| Total Operating Expenses | CN¥499.04 Million | CN¥503.36 Million | CN¥130.47 Million | CN¥1.28 Billion | CN¥1.18 Billion |
| Operating Income | CN¥1.68 Billion | CN¥438.99 Million | CN¥707.18 Million | CN¥8.69 Billion | CN¥8.37 Billion |
| EBITDA | CN¥1.74 Billion | CN¥557.08 Million | CN¥556.79 Million | CN¥8.95 Billion | CN¥8.76 Billion |
| EBIT | CN¥885.29 Million | CN¥-162.49 Million | CN¥-70.28 Million | CN¥8.58 Billion | CN¥8.62 Billion |
| Interest Expense | CN¥322.22 Million | CN¥135.67 Million | CN¥31.92 Million | CN¥21.11 Million | CN¥24.43 Million |
| Income Before Tax | CN¥1.61 Billion | CN¥442.82 Million | CN¥704.41 Million | CN¥8.65 Billion | CN¥8.35 Billion |
| Income Tax Expense | CN¥117.23 Million | CN¥54.75 Million | CN¥65.07 Million | CN¥1.19 Billion | CN¥1.34 Billion |
| Net Income | CN¥1.47 Billion | CN¥383.00 Million | CN¥629.07 Million | CN¥7.43 Billion | CN¥7.01 Billion |
Shandong Intco Medical Products Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Shandong Intco Medical Products Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CN¥34.63 Billion | CN¥27.08 Billion | CN¥21.48 Billion | CN¥20.62 Billion | CN¥12.93 Billion |
| Total Current Assets | CN¥21.95 Billion | CN¥15.60 Billion | CN¥10.24 Billion | CN¥10.76 Billion | CN¥8.51 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥6.74 Billion | CN¥723.21 Million | CN¥1.62 Billion | CN¥3.27 Billion | CN¥1.38 Billion |
| Net Receivables | CN¥1.46 Billion | CN¥1.13 Billion | CN¥555.36 Million | CN¥775.15 Million | CN¥699.51 Million |
| Inventory | CN¥1.27 Billion | CN¥1.15 Billion | CN¥1.00 Billion | CN¥1.08 Billion | CN¥847.45 Million |
| Property, Plant & Equipment | — | — | CN¥8.91 Billion | CN¥8.26 Billion | CN¥3.57 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CN¥16.95 Billion | CN¥10.78 Billion | CN¥5.43 Billion | CN¥4.50 Billion | CN¥3.49 Billion |
| Total Current Liabilities | CN¥14.68 Billion | CN¥8.62 Billion | CN¥3.15 Billion | CN¥2.08 Billion | CN¥2.23 Billion |
| Long-term Debt | CN¥166.80 Million | CN¥77.25 Million | CN¥51.59 Million | CN¥201.26 Million | CN¥230.09 Million |
| Net Debt | CN¥818.99 Million | CN¥-110.62 Million | CN¥-3.45 Billion | CN¥-4.71 Billion | CN¥-4.73 Billion |
| Total Stockholder Equity | CN¥17.40 Billion | CN¥16.03 Billion | CN¥15.81 Billion | CN¥15.87 Billion | CN¥9.34 Billion |
| Retained Earnings | CN¥15.53 Billion | CN¥14.17 Billion | CN¥13.87 Billion | CN¥13.66 Billion | CN¥7.34 Billion |
Shandong Intco Medical Products Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Shandong Intco Medical Products Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥1.08 Billion | CN¥502.41 Million | CN¥1.07 Billion | CN¥8.68 Billion | CN¥8.59 Billion |
| Capital Expenditures | CN¥1.79 Billion | CN¥1.44 Billion | CN¥1.72 Billion | CN¥5.44 Billion | CN¥2.89 Billion |
| Free Cash Flow | CN¥-710.37 Million | CN¥-936.28 Million | CN¥-649.76 Million | CN¥3.24 Billion | CN¥5.70 Billion |
| Investing Cash Flow | CN¥-3.87 Billion | CN¥-3.98 Billion | CN¥-1.87 Billion | CN¥-7.73 Billion | CN¥-4.01 Billion |
| Financing Cash Flow | CN¥1.42 Billion | CN¥3.01 Billion | CN¥549.05 Million | CN¥-833.25 Million | CN¥56.14 Million |
| Dividends Paid | CN¥338.28 Million | CN¥184.92 Million | CN¥412.20 Million | CN¥1.06 Billion | CN¥144.16 Million |
| Stock-Based Compensation | — | — | CN¥-98.63K | CN¥39.65 Million | CN¥49.84 Million |
| Depreciation | CN¥862.47 Million | CN¥723.50 Million | CN¥629.94 Million | CN¥368.62 Million | CN¥140.02 Million |
| Change in Cash | CN¥-1.30 Billion | CN¥-397.43 Million | CN¥19.69 Million | CN¥74.80 Million | CN¥4.34 Billion |
Shandong Intco Medical Products Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Shandong Intco Medical Products Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 0.34 | — | — |
| Jun 30, 2025 | 0.57 | — | — |
| Apr 28, 2025 | 0.55 | — | — |
| Dec 31, 2024 | 1.21 | — | — |
| Oct 28, 2024 | 0.16 | — | — |
| Jun 30, 2024 | 0.54 | — | — |
| Apr 23, 2024 | 0.36 | — | — |
| Feb 22, 2024 | 0.08 | — | — |